| 2022 | Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease
| GUT AND LIVER |
| 2022 | Analysis of Severe Hypoglycemia Among Adults With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
| JAMA NETWORK OPEN |
| 2022 | Renal Tubular Damage Marker, Urinary N-acetyl-β-D-Glucosaminidase, as a Predictive Marker of Hepatic Fibrosis in Type 2 Diabetes Mellitus
| DIABETES & METABOLISM JOURNAL |
| 2022 | Blood Pressure Levels and Risks of Dementia: a Nationwide Study of 4.5 Million People | HYPERTENSION |
| 2021 | Uric Acid Variability as a Predictive Marker of Newly Developed Cardiovascular Events in Type 2 Diabetes
| FRONTIERS IN CARDIOVASCULAR MEDICINE |
| 2021 | Ipragliflozin, an SGLT2 Inhibitor, Ameliorates High-Fat Diet-Induced Metabolic Changes by Upregulating Energy Expenditure through Activation of the AMPK/ SIRT1 Pathway
| DIABETES & METABOLISM JOURNAL |
| 2021 | Lobeglitazone: A Novel Thiazolidinedione for the Management of Type 2 Diabetes Mellitus
| DIABETES & METABOLISM JOURNAL |
| 2021 | Nonalcoholic fatty liver disease, diastolic dysfunction, and impaired myocardial glucose uptake in patients with type 2 diabetes | DIABETES OBESITY & METABOLISM |
| 2020 | Effect of Switching from Linagliptin to Teneligliptin Dipeptidyl Peptidase-4 Inhibitors in Older Patients with Type 2 Diabetes Mellitus
| DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY |
| 2020 | Dipeptidyl peptidase-4 inhibitor protects against non-alcoholic steatohepatitis in mice by targeting TRAIL receptor-mediated lipoapoptosis via modulating hepatic dipeptidyl peptidase-4 expression
| SCIENTIFIC REPORTS |
| 2020 | Sarcopenia is associated with non-alcoholic fatty liver disease in men with type 2 diabetes | DIABETES & METABOLISM |
| 2020 | Hepatic fibrosis is associated with total proteinuria in Korean patients with type 2 diabetes
| MEDICINE |
| 2020 | Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association
| DIABETES & METABOLISM JOURNAL |
| 2020 | Non-alcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes: a Korean cohort study
| CARDIOVASCULAR DIABETOLOGY |
| 2020 | SGLT2 Inhibition Modulates NLRP3 Inflammasome Activity via Ketones and Insulin in Diabetes With Cardiovascular Disease
| NATURE COMMUNICATIONS |
| 2020 | Gamma Glutamyltransferase and Risk of Dementia in Prediabetes and Diabetes
| SCIENTIFIC REPORTS |
| 2020 | Association Between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus
| DIABETES & METABOLISM JOURNAL |
| 2020 | Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk | AMERICAN JOURNAL OF GASTROENTEROLOGY |
| 2020 | Comparison of Renal Effects of Ezetimibe-Statin Combination Versus Statin Monotherapy: A Propensity-Score-Matched Analysis
| JOURNAL OF CLINICAL MEDICINE |
| 2020 | Ipragliflozin Additively Ameliorates Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Controlled with Metformin and Pioglitazone: A 24-Week Randomized Controlled Trial
| JOURNAL OF CLINICAL MEDICINE |
| 2020 | Association Between Serum Bilirubin and the Progression of Carotid Atherosclerosis in Type 2 Diabetes
| Journal of Lipid and Atherosclerosis |
| 2020 | Proteinuria is Associated with Carotid Artery Atherosclerosis in Non-Albuminuric Type 2 Diabetes: A Cross-Sectional Study
| JOURNAL OF CLINICAL MEDICINE |
| 2019 | Efficacy and Safety of Gemigliptin in Post-Transplant Patients With Type 2 Diabetes Mellitus | TRANSPLANTATION PROCEEDINGS |
| 2019 | The Effectiveness of Intermittent Fasting to Reduce Body Mass Index and Glucose Metabolism: A Systematic Review and Meta-Analysis
| JOURNAL OF CLINICAL MEDICINE |
| 2019 | Differential Effects of Thiazolidinediones and Dipeptidyl Peptidase-4 Inhibitors on Insulin Resistance and β-Cell Function in Type 2 Diabetes Mellitus: A Propensity Score-Matched Analysis
| DIABETES THERAPY |
| 2019 | Low-dose pioglitazone can ameliorate learning and memory impairment in a mouse model of dementia by increasing LRP1 expression in the hippocampus
| SCIENTIFIC REPORTS |
| 2019 | Efficacy and safety of fixed-dose combination therapy with gemigliptin (50 mg) and rosuvastatin compared with monotherapy in patients with type 2 diabetes and dyslipidaemia (BALANCE): A multicentre, randomized, double-blind, controlled, phase 3 trial | DIABETES OBESITY & METABOLISM |
| 2019 | Current Management of Type 2 Diabetes Mellitus in Primary Care Clinics in Korea
| Endocrinology and Metabolism (대한내분비학회지) |
| 2019 | Glucometabolic characteristics and higher vascular complication risk in Korean patients with type 2 diabetes with non-albumin proteinuria | Journal of Diabetes and Its Complications |
| 2019 | Predictive factors for the development of diabetes in cancer patients treated with phosphatidylinositol 3-kinase inhibitors | Cancer Chemotherapy and Pharmacology |
| 2019 | Spontaneous ketonuria and risk of incident diabetes: a 12 year prospective study | Diabetologia |
| 2019 | Comparison of hepatocellular carcinoma risk between patients treated with glimepiride and gliclazide | Diabetes & Metabolism |
| 2019 | Nonalcoholic Fatty Liver Disease in Diabetes. Part I: Epidemiology and Diagnosis
| DIABETES & METABOLISM JOURNAL |
| 2019 | Risk of Incident Dementia According to Metabolic Health and Obesity Status in Late Life: A Population-Based Cohort Study | JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM |
| 2019 | Nonalcoholic Fatty Liver Disease and Diabetes: Part II: Treatment
| DIABETES & METABOLISM JOURNAL |
| 2019 | Predictors of the Therapeutic Efficacy and Consideration of the Best Combination Therapy of Sodium-Glucose Co-transporter 2 Inhibitors
| DIABETES & METABOLISM JOURNAL |
| 2019 | Sodium-glucose cotransporter 2 inhibitors regulate ketone body metabolism via inter-organ crosstalk | DIABETES OBESITY & METABOLISM |
| 2018 | Relationship Between Circulating Netrin-1 Concentration, Impaired Fasting Glucose, and Newly Diagnosed Type 2 Diabetes
| FRONTIERS IN ENDOCRINOLOGY |
| 2018 | Clinical efficacy of the novel thiazolidinedione lobeglitazone in patients with type 2 diabetes | DIABETES & METABOLISM |
| 2018 | Effects of Combination Therapy of Statin and Thiazolidinedione on Vascular Inflammation
| KOREAN CIRCULATION JOURNAL |
| 2018 | Combining SGLT2 Inhibition With a Thiazolidinedione Additively Attenuate the Very Early Phase of Diabetic Nephropathy Progression in Type 2 Diabetes Mellitus
| FRONTIERS IN ENDOCRINOLOGY |
| 2018 | Efficacy and safety of ipragliflozin as an add-on therapy to sitagliptin and metformin in Korean patients with inadequately controlled type 2 diabetes mellitus: A randomized controlled trial
| DIABETES OBESITY & METABOLISM |
| 2018 | Effects of lobeglitazone, a novel thiazolidinedione, on adipose tissue remodeling and brown and beige adipose tissue development in db/db mice | INTERNATIONAL JOURNAL OF OBESITY |
| 2018 | Sarcopenia is associated with the risk of significant liver fibrosis in metabolically unhealthy subjects with chronic hepatitis B | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| 2018 | Elevated N-acetyl-beta-D-glucosaminidase, a urinary tubular damage marker, is a significant predictor of carotid artery atherosclerosis in type 1 diabetes, independent of albuminuria: A cross-sectional study | JOURNAL OF DIABETES AND ITS COMPLICATIONS |
| 2018 | Differential association of ezetimibe-simvastatin combination with major adverse cardiovascular events in patients with or without diabetes: a retrospective propensity score-matched cohort study
| SCIENTIFIC REPORTS |
| 2018 | Comparison of the Effects of Ezetimibe-Statin Combination Therapy on Major Adverse Cardiovascular Events in Patients with and without Diabetes: A Meta-Analysis
| Endocrinology and Metabolism (대한내분비학회지) |
| 2018 | Effects of Serum Albumin, Calcium Levels, Cancer Stage and Performance Status on Weight Loss in Parathyroid Hormone-Related Peptide Positive or Negative Patients with Cancer
| Endocrinology and Metabolism (대한내분비학회지) |
| 2018 | Waist-to-calf circumstance ratio is an independent predictor of hepatic steatosis and fibrosis in patients with type 2 diabetes | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2018 | Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients | JOURNAL OF HEPATOLOGY |
http://orcid.org/0000-0003-0542-2854
(7007118478)
